Abstract:Background Retinal vein occlusion (RVO) is one of the most frequent retinal vascular diseases. In this study, we aimed to investigate the predictive factors of visual outcome for RVO patients who underwent anti-vascular endothelial growth factor (VEGF) therapy. Methods RVO patients who underwent anti-VEGF treatment were recruited in this study from January 2018 to June 2020. Clinical data and optical coherence tomography (OCT) parameters were retrospectively reviewed. Best-corrected visual acuity (BCVA) was examined at baseline and after anti-VEGF therapy. Predictive factors associated with visual outcome were assessed by logistic regression model. Treatment-related adverse events were also recorded. Results The average logMAR BCVA was 0.91 at baseline and 0.70 at final examination ( P = 0.003). Among 75 patients, 41 experienced visual improvement were categorized as group A, the remaining 34 patients without improved vision were categorized as group B. Patients in group A demonstrated better visual outcomes, including decreased logMAR BCVA (average logMAR BCVA: 0.53 in group A vs. 0.91 in group B, P < 0.001) and central retinal thickness (CRT) (average CRT: 230.88 μm in group A vs. 404.97 μm in group B, P < 0.001) after anti-VEGF treatment. Multivariable analysis showed that injection frequency (odds ratio [OR], 2.623; 95% confidence interval [CI], [1.282–5.366]), hypertension (odds ratio [OR], 0.189; 95% CI [0.044–0.811]), hyperlipemia (odds ratio [OR], 0.195; 95% CI [0.040–0.941]) and external limiting membrane (ELM) disruption (odds ratio [OR], 0.148; 95% CI [0.032–0.691]) were all significantly associated with the visual outcome of RVO patients who underwent anti-VEGF treatment. In general, anti-VEGF therapy was feasible for all RVO patients, though the response to anti-VEGF was suboptimal in certain patients. Prognostic factors including injection frequency, hypertension, hyperlipemia and ELM disruption may all be useful to provide predictive information of visual outcome of RVO patients in response to anti-VEGF treatment.

Etiological factors and clinical outcomes in Non-Traumatic Non-Diabetec retinopathic vitreous hemorrhage

Analysis of Prognostic Factors in Non-Traumatic and Non-Diabetic Retinopathy Patients Undergoing Vitrectomy

Long-term surgical outcomes and prognostic factors for advanced-stage retinopathy of prematurity after vitrectomy

Non-Buckled Vitrectomy for Retinal Detachment with Inferior Breaks and Proliferative Vitreoretinophathy

Retrospective analysis of the etiology and drugs for vitreous hemorrhage caused by non-diabetic retinopathy and non-traumatic factors

Clinical Features And Outcomes Of Vitrectomy In Pediatric Ocular Injuries-Eye Injury Vitrectomy Study

Clinical Etiological Analysis of Severe Vitreous Hemorrhage in Venerable Age Patients

Effects of Vitrectomy in Conjunction with Chinese Medicinal Materials on Treatment of Proliferative Diabetic Retinopathy

Preliminary Access of Efficacy of Vitreoretinal Surgeries Without Endotamponade for Diabetic Tractional Retinal Detachment

A clinical study of vitrectomy for traumatic macular hole

Evaluation of Vitrectomy in Advanced Proliferative Diabetic Retinopathy

Analyze of Factors and Prognosis of Eyes Lost to Follow-Up in Retinal Vein Occlusive Disease Patients Receiving Anti-Vascular Endothelial Growth Factor Therapy

Risk factors, anatomical, and visual outcomes of injured eyes with proliferative vitreoretinopathy: eye injury vitrectomy study.

Factors Influencing Vitrectomy in Treating Penetrating Ocular Trauma Involving the Posterior Segment

Effect of anti-vascular endothelial growth factor on early-stage post-vitrectomy macular edema in patients with proliferative diabetic retinopathy

Visual outcomes and prognostic factors of early pars plana vitrectomy for open globe injury

An Analysis of the Prognosis and Factors of Vitrectomy for a Traumatic Macular Hole

Analysis of Result of Vitrectomy for Proliferative Diabetic Retinopathy in 544 Eyes

Prognosis factors analysis of vitrectomy for idiopathic macular hole

A retrospective study assessing the factors associated with visual outcome in retinal vein occlusion patients after anti-VEGF therapy

LONG-TERM RESULTS OF VITRECTOMY WITHOUT ENDOTAMPONADE IN PROLIFERATIVE DIABETIC RETINOPATHY WITH TRACTIONAL RETINAL DETACHMENT